| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Edesa Biotech, Inc.
13D/A
EDSA · 27966L306
|
16.3% |
8/25/2026
Event 8/21/2026
|
||||
| Pardeep Nijhawan Medicine Professional Corporation | 7.8% | |||||
| The Digestive Health Clinic Inc. | 0.2% | |||||
| 1968160 Ontario Inc. | 0.4% | |||||
| The New Nijhawan Family Trust 2015 | 0.2% | |||||
| Pardeep Nijhawan | 16.3% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.